Design, Synthesis and Bioevaluation of Two Series of 3‐[(1‐Benzyl‐1
<i>H</i>
‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3
<i>H</i>
)‐ones and
<i>N</i>
‐(1‐Benzylpiperidin‐4‐yl)quinazolin‐4‐amines
作者:Ta Thu Lan、Duong Tien Anh、Hai Pham‐The、Do Thi Mai Dung、Eun Jae Park、Sun Dong Jang、Joo Hee Kwon、Jong Soon Kang、Nguyen Thi Thuan、Sang‐Bae Han、Nguyen‐Hai Nam
DOI:10.1002/cbdv.202000290
日期:2020.7
3‐[(1‐Benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3H)‐one significantly induced early apoptosis and arrested the SW620 cells at G2/M phase. From this study, two compounds of N‐(1‐benzylpiperidin‐4‐yl)quinazolin‐4‐amines could serve as new leads for further design and AChE inhibitors, while 3‐[(1‐benzyl‐1H‐1,2,3‐triazol‐4‐yl)methyl]quinazolin‐4(3H)‐one could serve as a new lead for the design and development
两个系列的 3-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones 和 N-(1-benzylpiperidin-4-yl)quinazolin-4 - 胺最初被设计为潜在的乙酰胆碱酯酶抑制剂。生物学评估表明,N-(1-benzylpiperidin-4-yl)quinazolin-4-amines 显着抑制 AChE 活性。特别是,与多奈哌齐相比,发现其中的两种化合物最有效,相对 AChE 抑制百分比为 87%。与 AChE 的对接研究显示多奈哌齐和四种衍生物之间的相互作用相似。N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines 也表现出显着的 DPPH 清除作用。这两个系列的化合物还对三种人类癌细胞系,包括 SW620(人类结肠癌)、PC-3(前列腺癌)、和 NCI-H23(肺癌),其中